110
Participants
Start Date
September 19, 2019
Primary Completion Date
November 12, 2021
Study Completion Date
November 12, 2021
ampreloxetine
Oral tablet, QD
MHATNP -Sv. Naum- EAD, Sofia
MHATNP Sv. Naum EAD Clinic of Neurological Diseases for Locomotor Disorders, Sofia
Bispebjerg Hospital, Copenhagen
Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre, Clayton
Universitätsklinikum Tulln Abteilung fur Neurologie, Tulln
Ospedaliera Santa Maria Terni, Terni
Praxis Dr. med. Christian Oehlwein, Gera
Hospital del Mar, Barcelona
New York University School of Medicine, New York
Charite - Campus Virchow- Klinikum, Klinik fur Neurologie, Berlin
Fondazione IRCCS CA Granda Ospedale Maggiore Pliclinico - U.O. Neurologia, Milan
CNE Acad O.I. Yushchenko Vinnytsia Reg Psychoneurological Hospital of Vinnytsia Regional Council, Department of Neurology, Vinnytsia
Hospital Universitario de La Princesa, Madrid
CHU de Nîmes - Hôpital Caremeau, Nîmes
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
Neurostudies, Inc., Port Charlotte
Vanderbilt University Medical Center, Nashville
Universita di Bologna-Clinica Neurologica-Dipartimento di Scienze Neurologiche Ospedale Bellaria, Bologna
UO Farmacia Centralizzata OM (SC) Ospedale Maggiore, Bologna
Specjalistyczna Praktyka Lekarska prof.Grzegorz Opala, Katowice
University of Cincinnati Medical Center (UCGNI), Cincinnati
Hospital de Cruces, Bilbao
Tartu University Hospital, Tartu
Mayo Clinic - Rochester, Rochester
NorthShore University HealthSystem, Glenview
Rush University Medical Center, Chicago
Municipal Instituion of Health: Kharkiv Public Outpatient Clinic 9, Kharkiv Medical Academy of Post-Graduate Education, Department of General Practice - Family Medicine, Kharkiv
University of Kansas Medical Center, Kansas City
University of Texas Southwestern Medical Center, Dallas
Lviv Regional Clinical Hospital, Lviv
Colorado Springs Neurological Associates, Colorado Springs
AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno
Oregon Health & Science University (OHSU), Portland
Inland Northwest Research, Spokane
SBEI APE Russian Medical Academy of Postgraduate Education of the MoH of the RF, Moscow
"FSBI National Medical Research Centre of psychiatry and neurology named after V.M. Bekhterev of the MOH of the Russian Federation", Saint Petersburg
Limited Liability Company City Neurological Center Sibneiromed, Novosibirsk
State Budgetary Institution of Healthcare of Novosibirsk region City Clinical Hospital No. 34, Novosibirsk
Federal State Budgetary Institution Federal Sibirian Scientific and Clinical Center of Federal Medico-Biological Agency, Krasnoyarsk
Federal Sibirian Scientific and Clinical Center of Federal Medico-Biological Agency, Krasnoyarsk
Tel Aviv Sourasky Medical Center, Tel Aviv
Concord Hospital, Neurosciences Department, Concord
Perron Institute for Neurological and Translational Science, Nedlands
Montreal Neurological Institute & Hospital, Montreal
Fondazione PTV - Policlinico Tor Vergata I U.0.C. Neurologia, Roma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS / Istituto di Neurologia - Ambulatorio Disturbi del Movimento, Roma
New Zealand Brain Research Institute, Christchurch
Krakowska Akademia Neurologii Sp z o.o. Centrum Neurologii Klinicznej, Krakow
Instytut Zdrowia Dr Boczarska-Jedynak SP. Z 0.0., SP. K., Oświęcim
Neuro-Care Sp. z o.o. sp. Komandytowa, Siemianowice Śląskie
ETG Warszawa, Warsaw
Specjalistyczn.e Gabinety Sp. Z o.o., Warsaw
Campus Neurologico Senior, Torres Vedras
The National Hospital for Neurology & Neurosurgery, London
Re:Cognition Health Ltd, London
Lead Sponsor
Theravance Biopharma
INDUSTRY